Methyl 1-(pyridin-2-yl)-4,5,6,7-tetrahydro-1H-indazole-5-carboxylate

Catalog No. :
ACTJAN538
CAS No. :
68587-29-1
Molecular Formula :
C14H15N3O2
Molecular Weight :
257.29

IUPAC Name:methyl 1-(pyridin-2-yl)-4,5,6,7-tetrahydro-1H-indazole-5-carboxylate

Methyl 1-(pyridin-2-yl)-4,5,6,7-tetrahydro-1H-indazole-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$825.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 1-(pyridin-2-yl)-4,5,6,7-tetrahydro-1H-indazole-5-carboxylate
IUPAC Namemethyl 1-(pyridin-2-yl)-4,5,6,7-tetrahydro-1H-indazole-5-carboxylate
Molecular FormulaC14H15N3O2
Molecular Weight257.29
SMILESO=C(C1CC2=C(N(C3=NC=CC=C3)N=C2)CC1)OC
InChI KeyPEDNKWQOEGMIOZ-UHFFFAOYSA-N
SynonymMethyl 1-(pyridin-2-yl)-4,5,6,7-tetrahydro-1H-indazole-5-carboxylate;methyl 4,5,6,7-tetrahydro-1-(pyridin-2-yl)-1H-indazole-5-carboxylate;1H-Indazole-5-carboxylic acid, 4,5,6,7-tetrahydro-1-(2-pyridinyl)-, methyl ester
CAS No.68587-29-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTJAN538 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRUCB785 route compound structure diagram
    ACRUCB78551169-05-2 In Stock
  4. Then
  5. ACTJAN538 route product structure diagram
    ACTJAN53868587-29-1
Inquiry

2. ACTJAN538 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTJAN538 route product structure diagram
    ACTJAN53868587-29-1
Inquiry

Comments (0)